Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes. (Q49598911)
Jump to navigation
Jump to search
scientific article published on 12 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes. |
scientific article published on 12 October 2016 |
Statements
1 reference
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes. (English)
1 reference
Ravi P Nargund
1 reference
Liangqin Guo
1 reference
Dann L Parker
1 reference
Yi Zang
1 reference
Ramzi F Sweis
1 reference
Weiguo Liu
1 reference
Edward C Sherer
1 reference
Nicole Buist
1 reference
Jenna Terebetski
1 reference
Terri Kelly
1 reference
Randal Bugianesi
1 reference
Birgit T Priest
1 reference
Karen H Dingley
1 reference
Xiaofang Li
1 reference
Stan Mitelman
1 reference
Gino Salituro
1 reference
Maria E Trujillo
1 reference
Michele Pachanski
1 reference
Melissa Kirkland
1 reference
Mary Ann Powles
1 reference
George J Eiermann
1 reference
Yue Feng
1 reference
Jin Shang
1 reference
Andrew D Howard
1 reference
Feroze Ujjainwalla
1 reference
Christopher J Sinz
1 reference
John S Debenham
1 reference
Scott D Edmondson
1 reference
William K Hagmann
1 reference
Derun Li
1 reference
12 October 2016
1 reference
1 reference
7
1 reference
1107-1111
1 reference
12
1 reference
Identifiers
1 reference
1 reference
1 reference